- Home
- SQFT vs ADXN Comparison
SQFT vs ADXN Comparison
Compare SQFT & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- ADXN
- Stock Information
- Founded
- SQFT 1999
- ADXN 2002
- Country
- SQFT United States
- ADXN Switzerland
- Employees
- SQFT N/A
- ADXN N/A
- Industry
- SQFT Real Estate Investment Trusts
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- ADXN Health Care
- Exchange
- SQFT Nasdaq
- ADXN Nasdaq
- Market Cap
- SQFT 7.7M
- ADXN 8.0M
- IPO Year
- SQFT 2020
- ADXN N/A
- Fundamental
- Price
- SQFT $5.55
- ADXN $10.70
- Analyst Decision
- SQFT
- ADXN Strong Buy
- Analyst Count
- SQFT 0
- ADXN 1
- Target Price
- SQFT N/A
- ADXN $30.00
- AVG Volume (30 Days)
- SQFT 13.1K
- ADXN 58.4K
- Earning Date
- SQFT 11-11-2025
- ADXN 09-01-2025
- Dividend Yield
- SQFT N/A
- ADXN N/A
- EPS Growth
- SQFT N/A
- ADXN N/A
- EPS
- SQFT N/A
- ADXN 0.10
- Revenue
- SQFT $18,052,597.00
- ADXN $278,508.00
- Revenue This Year
- SQFT $23.63
- ADXN $86.57
- Revenue Next Year
- SQFT N/A
- ADXN N/A
- P/E Ratio
- SQFT N/A
- ADXN $0.85
- Revenue Growth
- SQFT N/A
- ADXN N/A
- 52 Week Low
- SQFT $4.19
- ADXN $6.51
- 52 Week High
- SQFT $23.00
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- SQFT 55.93
- ADXN 78.58
- Support Level
- SQFT $4.62
- ADXN $7.70
- Resistance Level
- SQFT $5.80
- ADXN $8.21
- Average True Range (ATR)
- SQFT 0.32
- ADXN 0.22
- MACD
- SQFT 0.09
- ADXN 0.20
- Stochastic Oscillator
- SQFT 78.81
- ADXN 68.97
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.